Healio
›
Hematology/Oncology
›
Head/Neck Cancer
›
News
-
Cover Stories
-
-
HemOnc Today, December 10, 2012
-
Not long ago, esophageal adenocarcinoma was an extremely rare cancer.
During the past 40 years, however, incidence has increased dramatically worldwide —...More
»
-
FDA approvals
Perspective
-
-
HemOnc Today, December 25, 2012
-
The FDA today approved cabozantinib to treat patients with metastatic medullary thyroid cancer.
Cabozantinib (Cometriq, Exelixis) also...More
»
-
In the Journals
-
-
HemOnc Today, December 10, 2012
-
Patients with oral squamous cell carcinoma who received an induction chemotherapy regimen had similar survival outcomes as those who did not receive...More
»
-
In the Journals
-
-
Endocrine Today, December 2012
-
More than 85% of patients with differentiated thyroid cancer in Germany did not have a lower life expectancy when compared with the general population,...More
»
-
Meeting News Coverage
-
-
OSN Retina, December 2012
-
CHICAGO — Novel and advanced technologies are critical for the evaluation and management of patients with ocular malignancies, a speaker said here.
...More
»
-
In the Journals
-
-
HemOnc Today, December 10, 2012
-
The combination of clinical assessment and a gene expression signature cut undetected nodal metastases in half in a cohort of patients with early-stage...More
»
-
-
-
Endocrine Today, December 2012
-
The American Thyroid Association has released the first set of comprehensive guidelines for the management of anaplastic thyroid cancer, a rare but lethal...More
»
-
In the Journals
-
-
HemOnc Today, December 25, 2012
-
Transoral robotic surgery through the mouth is a safe and effective procedure for patients with head and neck cancers, according to results of a...More
»
-
Meeting News Coverage
-
-
HemOnc Today, November 25, 2012
-
The tricyclic antidepressant doxepin reduces oral mucositis when used as a mouth rinse, according to findings of a randomized study presented at the 2012...More
»
-
Imaging Analysis
-
-
HemOnc Today, November 25, 2012
Daniel E. Meltzer, MD; Esha Gollapalle, MD; Grigorios Chrysofakis , MD; Ippolito Modica, MD; Michael Chung, MD; Munir Ghesani, MD
-
A 48-year-old black man with a history of chronic hepatitis C and HIV, well controlled on highly active antiretroviral therapy, presented with a 3-month...More
»